 |
 |
Selected biotechnology start-ups that are making the news. Companies are selected on the basis of the track record of their founding scientists, the novelty and breadth of application of their technologies, the experience of their management, and potential for access to defined and lucrative target markets. Click on the map below to access companies in a particular region. As time progresses, we hope to add more biotechnology start-ups from around the world.
|
US East Coast
Chromocell
August 2005
Serenex
April 2005
Metamorphosis from tool company to drug discovery engine.
GlycoFi
November 2003
Making drugs in yeast.
Chromatin
August 2003
Building plant chromosomes.
Intronn
July 2003
Gene therapy gets smart.
Alnylam
June 2003
Tackling major diseases with tiny RNAs
Mojave Therapeutics
June 2002
Using Javelins to deliver disease-related antigens to immune
cells
Microbia
June 2002
Exploiting microbial circuitry to fight infection
Archemix
June 2002
An RNA evolution in drug discovery?
Cell Based Delivery
June 2001
Engineering muscle cells for implantable drug delivery.
MacroGenics
June 2001
A fresh perspective on monoclonal antibodies.
ExonHit Therapeutics
June 2001
Capitalizing on the human spliceosome.
PTC Therapeutics
June 2001
Targeting therapeutics against RNA translation.
Cellular Genomics
June 2001
Getting straight to the molecular target.
US West Coast
Commercializing synthetic biology
July 2005
Amyris Biotechnologies and Codon Devices offer entrepreneurs and investors a hint of the commercial strategies to come in synthetic biology commercialization.
Cellerant Therapeutics
February 2005
Targeting multiple diseases with a single stem cell type.
Anadys Pharmaceuticals
June 2003
Piecing together the puzzle, while focusing on antivirals.
Signature Bioscience
June 2001
Catching proteins in action.
Protein Pathways
June 2001
Discovering conservation among molecular targets.
Quorex Pharmaceuticals
June 2001
New antimicrobials quiet bacterial talk.
Canada
Caprion Pharmaceuticals
June 2002
Putting proteins in context
Europe
Ablynx
December 2003
Cutting antibodies down to size
m-phasys
June 2003
Optimizing membrane protein expression.
METabolic EXplorer
June 2003
Iterative rounds of modeling and wet biology yield industrially optimized bacteria.
Cellzome
June 2002
Fishing around for proteins
Axxima Pharmaceuticals
June 2002
Creating a firewall against infection
BioVex
June 2002
Heavy-weight viruses for clearing cancers
Pieris ProteoLab
June 2002
Improving on antibodies
Asia
Can-Fite BioPharma
April 2004
Putting some muscle into the fight against cancer.
Semorex
June 2003
Can molecularly imprinted polymers give antibodies a run for their money?
ES Cell International
June 2003
Navigating the uncertainties of stem cell–based therapies.
Australia & New Zealand
Human Genetic Signatures
June 2003
Exploiting DNA methylation patterns in aging.
|
